Hans Bentzen - Concepedia

Author

Hans Bentzen

Also Known As

Bentzen, H, Bentzen, Hans Herluf Nørregaard, H. BENTZEN, H. Bentzen, H. H. Bentzen, H. H. N. Bentzen, H. Herluf Bentzen, Hans BENTZEN, Hans Bentzen, Hans H. Bentzen

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Aarhus University Hospital Rigshospitalet Helsinki University Hospital Copenhagen University Hospital Odense University Hospital

About

Hans Bentzen is an author at Aarhus University Hospital specializing in medicine, cancer research, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	614
2	Health Sciences	4	4	543
3	Social Sciences	1	1	11
4	Applied Physiology	1	1	33
5	Cell Biology	1	1	11

Hans Bentzen

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Nordic <scp>MCL</scp>2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by <scp>BEAM</scp> or <scp>BEAC</scp> + autologous stem‐cell support: still very long survival but late relapses do occur Christian H. Geisler, Arne Kolstad, Anna Laurell, British Journal of Haematology Cell TherapyImmunologyPathologyCell Replacement TherapyImmunotherapy	2012	265
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (<scp>MCL</scp>2): prolonged remissions without survival plateau Christian Winther Eskelund, Arne Kolstad, Mats Jerkeman, British Journal of Haematology ImmunologyPathologyHematological MalignancyOncologyHematology	2016	207
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma Arne Kolstad, Anna Laurell, Mats Jerkeman, Blood	2014	103
Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans Robert S. Pedersen, Hans Bentzen, Jesper Nørgaard Bech, American Journal of Physiology-Renal Physiology	2001	89
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years Arne Kolstad, Lone Bredo Pedersen, Christian Winther Eskelund, Biology of Blood and Marrow Transplantation	2016	62
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load Robert S. Pedersen, Hans Bentzen, Jesper Nørgaard Bech, Kidney International UrologyChronic Heart FailureRenal FunctionSodium HomeostasisMedicine	2003	49
A population‐based study of prognosis in advanced stage follicular lymphoma managed by watch and wait Tarec Christoffer El‐Galaly, Anders Ellern Bilgrau, Peter de Nully Brown, British Journal of Haematology Surgical OncologyCancer ManagementImmunologyPathologyPopulation‐based Study	2015	38
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3 Christian Winther Eskelund, Arne Kolstad, Ingrid Glimelius, HemaSphere	2020	34
Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure Hans Bentzen, Robert S. Pedersen, Ole Nyvad, International Journal of Cardiology Heart FailureKinesiologyPhysical ActivityChronic Heart FailureNatriuretic Peptides	2004	33
The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor Maja Dam Andersen, Peter Kamper, Alexander D'Amore Lindholm, Leukemia & lymphoma/Leukemia and lymphoma	2018	32

Page 1